Works matching IS 09340874 AND DT 2019 AND VI 32 AND IP 11


Results: 12
    1
    2

    Risks and benefits of everolimus.

    Published in:
    Transplant International, 2019, v. 32, n. 11, p. 1124, doi. 10.1111/tri.13489
    By:
    • Budde, Klemens;
    • Halleck, Fabian
    Publication type:
    Article
    3
    4

    Efficacy and safety of prolonged‐release tacrolimus in stable pediatric allograft recipients converted from immediate‐release tacrolimus – a Phase 2, open‐label, single‐arm, one‐way crossover study.

    Published in:
    Transplant International, 2019, v. 32, n. 11, p. 1182, doi. 10.1111/tri.13479
    By:
    • Rubik, Jacek;
    • Debray, Dominique;
    • Kelly, Deirdre;
    • Iserin, Franck;
    • Webb, Nicholas J. A.;
    • Czubkowski, Piotr;
    • Vondrak, Karel;
    • Sellier‐Leclerc, Anne‐Laure;
    • Rivet, Christine;
    • Riva, Silvia;
    • Tönshoff, Burkhard;
    • D'Antiga, Lorenzo;
    • Marks, Stephen D.;
    • Reding, Raymond;
    • Kazeem, Gbenga;
    • Undre, Nasrullah
    Publication type:
    Article
    5

    Prospective randomized study comparing everolimus and mycophenolate sodium in de novo kidney transplant recipients from expanded criteria deceased donor.

    Published in:
    Transplant International, 2019, v. 32, n. 11, p. 1127, doi. 10.1111/tri.13478
    By:
    • Ferreira, Alexandra Nicolau;
    • Felipe, Claudia Rosso;
    • Cristelli, Marina;
    • Viana, Laila;
    • Mansur, Juliana;
    • Paula, Mayara;
    • Wagner, Daniel;
    • Marco, Renato;
    • Gerbase‐DeLima, Maria;
    • Proença, Henrique;
    • Aguiar, Wilson;
    • Medina‐Pestana, Jose;
    • Tedesco‐Silva Junior, Helio
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12

    Issue Information.

    Published in:
    Transplant International, 2019, v. 32, n. 11, p. 1107, doi. 10.1111/tri.13304
    Publication type:
    Article